1. Oxymatrine suppresses the growth and invasion of MG63 cells by up-regulating PTEN and promoting its nuclear translocation
   Ming He et al, 2017, Oncotarget CrossRef
2. High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog)
   Keith A. Strand et al, 2020, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef
3. Epigenetic Small-Molecule Modulators Targeting Metabolic Pathways in Cancer
   Dipanwita Das et al, 2022, Metabolism and Epigenetic Regulation: Implications in Cancer CrossRef
4. Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas
   Naofumi Asano et al, 2019, Scientific Reports CrossRef
5. PTEN in osteosarcoma: Recent advances and the therapeutic potential
   Chuanxi Zheng et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
6. Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment
   Julia Krushkal et al, 2016, Clinical Epigenetics CrossRef
7. The correlation between the methylation of PTEN gene and the apoptosis of osteosarcoma cells mediated by SeHA nanoparticles
   Yanhua Wang et al, 2019, Colloids and Surfaces B: Biointerfaces CrossRef
8. Understanding and targeting anoikis in metastasis for cancer therapies
   Farzad  Sattari Fard et al, 2023, Cell Biology International CrossRef
9. Oncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies
   Yongming Xi et al, 2015, Journal of Cellular Biochemistry CrossRef
10. PI3K/Akt signaling in osteosarcoma
    Jian Zhang et al, 2015, Clinica Chimica Acta CrossRef
11. MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression
    HONGMOU YUAN et al, 2015, Oncology Reports CrossRef
12. HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU
    Jun Sun et al, 2021, Bioscience Reports CrossRef
13. Characterizing Osteosarcoma Through PTEN and PI3K: What p53 and Rb1 Can’t Tell Us
    Matthew G. Cable et al, 2017, Osteosarcoma - Biology, Behavior and Mechanisms CrossRef
14. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling
    Jessica M Foley et al, 2015, Journal of Translational Medicine CrossRef
15. Expression of NF-κB and PTEN in osteosarcoma and its clinical significance
    Teng Gong et al, 2017, Oncology Letters CrossRef
16. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
    Mehrdokht Sadrkhanloo et al, 2023, Pathology - Research and Practice CrossRef
17. Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and PTEN/PI3K/AKT pathway in osteosarcoma cells
    Jiali Yang et al, 2023, Journal of Photochemistry and Photobiology B: Biology CrossRef
18. Epigenetic DNA Demethylation Causes Inner Ear Stem Cell Differentiation into Hair Cell-Like Cells
    Yang Zhou et al, 2016, Frontiers in Cellular Neuroscience CrossRef